CD274 and cancer: Thus, inactivated rotavirus may be prepared as a therapeutic cancer vaccine to revert “cold” tumors into immune-infiltrated “hot” tumors, and improve anti-PD1, anti-PD-L1 or anti-CTLA4 therapy.